PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
50.49%
Net income growth similar to CRK's 47.06%. Walter Schloss would find parallel expansions or market conditions in both firms’ profitability.
-21.59%
Both reduce yoy D&A, with CRK at -51.82%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
35.94%
Well above CRK's 70.86% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
80.00%
SBC growth well above CRK's 0.43%. Michael Burry would flag major dilution risk vs. competitor’s approach.
-42.00%
Negative yoy working capital usage while CRK is 283.99%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-42.00%
Negative yoy usage while CRK is 136.04%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
256.67%
Well above CRK's 338.51%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-1.10%
Negative yoy CFO while CRK is 967.45%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
40.80%
CapEx growth well above CRK's 12.12%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
668.69%
Acquisition growth of 668.69% while CRK is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
-10.59%
Negative yoy purchasing while CRK stands at 0.00%. Joel Greenblatt sees a near-term liquidity advantage unless competitor’s new investments produce outsized returns.
-40.80%
We reduce yoy sales while CRK is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
40.59%
We have some outflow growth while CRK is negative at -100.18%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
153.68%
We have mild expansions while CRK is negative at -146.99%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-4166.67%
We cut debt repayment yoy while CRK is 94.14%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.